Research programme: metabolic disorders therapy - Maxygen
Alternative Names: Maxy 58; Maxy 70Latest Information Update: 10 Jun 2013
At a glance
- Originator Maxygen
- Class Proteins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Diabetes mellitus; Metabolic disorders; Obesity
Most Recent Events
- 10 Jun 2013 Discontinued - Preclinical for Diabetes mellitus in USA (unspecified route)
- 10 Jun 2013 Discontinued - Preclinical for Metabolic disorders in USA (unspecified route)
- 10 Jun 2013 Discontinued - Preclinical for Obesity in USA (unspecified route)